INTRODUCTION
Functional dyspepsia (FD) is defined as the presence of gastrointestinal symptoms, such as epigastric pain, epigastric burning, postprandial fullness, and early satiation, nausea or vomiting in the absence of any organic, systemic, or metabolic disease. 1 The pathophysiology of FD has been widely investigated, but is still not well identified. 2 FD is frequently encountered in clinical practice. FD was found to affect up to 23.5% of the population in a study in Guangzhou, China. 3 A large population-based study in Europe showed that 20.6% of patients had suffered from epigastric symptoms during the preceding 12-month period. 4 Although there is no specific remedy for FD, it is believed that improvement of living habits and psychological management are beneficial to these patients. 5 Routine therapies commonly used are eradication of Helicobacter pylori, dopaminergic receptor blockers, sucralfate, and bismuth subsalicylate, or even antidepressants. Some patients may be symptom-free for years, while some continue to be symptomatic without the help of medicine. TCM also plays an important role in improving the symptoms of FD in the Chinese mainland. In TCM, FD is considered as nearly equivalent to the TCM term "stuffiness and fullness", 6 which is divided into different syndromes according to different clinical symptoms and signs. The basic syndromes include liver-stomach disharmony syndrome, fluid and food retention syndrome, dampness-heat of spleen and stomach syndrome, cold and heat in complexity syndrome, and spleen-stomach weakness syndrome. 7 The syndrome of liver-stomach disharmony and spleenstomach weakness syndrome are predominant among those FD outpatients. 8 Epidemiology shows some relation between the occurrence of dyspepsia and recent events in a patient's life, as well as psychosocial factors. 9 Additionally, 54.2% of inpatients with FD have mood disturbances, 3 implying that emotional instability might be the cause of some symptoms of FD. In the theory of TCM, emotional instability is closely related to disorder of liver-Qi, which leads to the syndrome of liver-stomach disharmony.
To determine whether TCM offers advantages over routine Western Medicine in treating FD with liver-stomach disharmony syndrome, we undertook a systematic review and meta-analysis of all relevant randomized controlled trials (RCTs).
METHODS

Search strategy
We identified studies by searching the following databases: Pubmed, China national knowledge infrastructure Data-base (1994 to May 2012), Wanfang Data (1989 to May 2012), VIP Information (1989 to May 2012), and the Cochrane Library. Search terms were "functional dyspepsia", "liver-stomach disharmony" and "disharmony between the liver and stomach", and "random control", "clinical trial", and "TCM". Studies published in English and Chinese were considered, and only data available in the full text were reviewed.
Inclusion and exclusion criteria
Studies were eligible for inclusion in the meta-analysis if they met all of the following criteria: 1) the study was designed as an RCT; 2) patients included in the study were diagnosed with FD according to Rome III, 10 and the TCM syndrome must be liver-stomach disharmony; 6 3) TCM versus prokinetic agents was investigated; 4) criteria for successful treatment were clearly stated and treatment success was measured including the symptom scores; and 5) the treatment course lasted for 2 weeks or more. Trials were excluded for the following reasons: 1) studies were not RCTs; 2) the experimental group contained both TCM and prokinetic agents; and 3) repeatedly published studies.
Data extraction
To avoid bias in the data extraction process, two reviewers (Mingjin Zhu and Wei Xia) independently abstracted and compared the results. All data were checked for internal consistency, and disagreements were resolved by discussion between the two reviewers and by seeking the opinion of a senior reviewer (Chuijie Wang) if necessary. Details abstracted from the studies, including the name of the first author, year of publication, number and mean age of the participants, male-female ratio, and adverse reactions were listed. When more than one published article described a single study, we extracted data from the study providing the most detailed information.
Assessment of methodological quality
Included RCTs were strictly evaluated according to the methods of evaluating risk of bias as described in the Cochrane Handbook 4.2.2 for Systematic Reviews of Interventions (version 2004). The quality of trials was assessed by examining: randomization, the allocation concealment, baseline characteristics, blinding, withdrawals/dropouts, and selective reporting of outcomes, which were ranked by A (low risk of bias), B (moderate risk of bias), and C (high risk of bias). We also used the modified Jadad scoring system for quality assessment. 11
Data analysis
Review Manager 5.0.24 provided by the Cochrane Collaboration was used to analyze collected data. Odds ratios (ORs) were used for dichotomous data, with 95% confidence intervals (CIs). The Chi-squared test for homogeneity was carried out to determine whether the distribution of results was compatible with the assumption that differences between trials were due to chance variation alone. Heterogeneity was presented as significant when I 2 was over 50% or P<0.1, and a random effect model was used for the meta-analysis. If I 2 was less than 50% and P>0.1, there was significant heterogeneity, and a fixed effect model was used. A funnel plot was carried out to assess publication bias. 12
Sensitivity analysis
To evaluate the effect of methodological characteristics of RCTs on the results of this meta-analysis, sensitivity analysis was used to reanalyze the data by changing inclusion criteria or using different statistical methods. If the sensitivity analysis was close to the results, this strengthened the level of confidence.
RESULTS
In this review, 53 articles were retrieved from the five above-mentioned electronic databases. Thirty-eight articles were excluded by reading the headlines and abstract, because they were not controlled trials (n=5), they were not randomized (n=7), the experimental group was TCM combined with other drugs (n=10), both groups were TCM therapies (n=4), they contained other TCM syndromes (n=10), or were duplicated articles (n=2). The rest of the 15 articles were carefully reviewed. Two articles described the same studies, and therefore, we chose the detailed study. The other excluded article showed different data between the abstract and the content. Therefore, a total of 13 studies involving 1153 patients were included in the systematic review. [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] All 13 studies included were of a parallel design, single center, and had a positive control group. Trials were only performed in China and were written in Chinese. The characteristics of included trials are shown in Tables 1 and 2 .
Methodological quality of included trials
All trails were of poor methodological quality and at high risk of bias. Only one trial 24 barely met the quality grade B and with a modified Jadad score of 2 points, while the rest were grade C with a modified Jadad score of 1 point. All studies were described as randomized, but only four trials 14, 16, 18, 25 presented specific methods of allocation sequence. An RCT with high quality and low bias should have blinding and allocation concealment strictly designed and conducted. However, none of the trials mentioned blinding and allocation concealment. Dropouts were sometimes inevitable when conducting clinical trials, and intention-to-treat should be taken into consideration, but the identified studies failed to provide any data on dropouts. Only two studies 21, 24 mentioned adverse effects, while others failed to provide any specific information about adverse effects.
Effective rate meta-analysis
The 13 studies compared TCM interventions with prokinetic agents, and 12 studies [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] reported total effective rates: the group using TCM therapy varied from 83.3% to 93.33% , while the group of prokinetic agents varied from 56.7% to 82.2% [OR: 3.2, 95%CI (2.27, 4.51)]. There was no heterogeneity among trials (χ 2 =3.34, P=0.99>0.1, I 2 =0% ), and therefore, the M-H fixed-effect model was used. The tests for overall effect showed that TCM therapy was better than prokinetic agents, and there was a statistical significance in effective rate (P<0.001) between the TCM group and prokinetic agents ( Figure 1 ). One study 25 only compared single symptoms separately. The bias of those 12 trials was that a funnel plot was used to assess publication bias (Figure 2 ). The funnel-shape was slightly asymmetrical, indicating that there might be publication bias in those studies.
Cure rate meta-analysis
Nine studies 13, [16] [17] [18] [20] [21] [22] [23] [24] described the cure rate. The Peto fixed effects model is the more appropriate model for rare events. 26 The cure rate is a small probability event, and therefore, we used the Peto OR to reduce bias. The incorporated data showed that TCM therapy outweighed the prokinetic agents in curing FD (Peto OR: 2.26, 95%CI=[1.61, 3.18]), and there was no heterogeneity (χ 2 =3.15, P=0.92; I²=0%).
Subgroup analyses
Herbal therapy versus domperidone alone with 4 weeks' course: Eight studies 13, 14, 16, 17, 20, 21, 23, 24 compared Chinese herbs alone with domperidone alone in a 4-week course. There was a significantly higher effective rate in herbal therapy than domperidone alone [663 patients OR: 2.99, 95% CI (1.93, 4.63)], and there was no significant heterogeneity (χ 2 =2.98, P= 0.89, I²=0%). Herb therapy versus mosapride: Two studies 18, 19 compared Chinese herbs with mosapride. The merged analysis showed that Chinese herbal medicine achieved a higher response rate than mosapride [OR: 3.98, 95% CI (1.50, 10.54)], and there was no significant heterogeneity (χ 2 =2.78, P=0.92, I²=0%) ( Figure 3 ).
Sensitivity analyses
We renewed the analysis according to methodological quality (with specific random method or follow-up). Five 14, 16, 18, 24, 25 of the studies with a relatively higher quality were selected, and their merged data showed that there was a significant difference between TCM therapy and the control groups [OR: 3.37, 95% CI (1.72, 6.62]), and there was no significant heterogeneity in this analysis (χ 2 =2.48, P=0.90, I² =0% ). This result agrees with the whole analysis.
The selective ratio for single Chinese herbs in the identified studies
The Chinese herbs were chosen by the researchers according to the principle of TCM treatment in treating liver-stomach disharmony syndrome, namely dispersing the depressed liver-Qi and regulating the stomach. To clearly understand Chinese herbal medicine, we performed a simple statistical analysis on the frequency of Chinese herbs used in these 13 trials. The distribution of these herbs is shown in Figure 4 . Baishao (Radix Paeoniae), Chaihu (Radix Bupleuri), and Gancao (Radix Reference Pang J 2009 13 Wang HF 2010 14 Zou YJ 2007 15 Yang XJ 2009 16 Chen W 2005 17 Zhou YX 2012 18 Chen Y 2004 19 Zhang ZL 2007 20 Tan HL 2009 21 Li JS 2008 22 Li D 2011 23 Li YH 2009 24 Table 1 Characteristics of the studies included in the meta-analysis Note: TCM: Traditional Chinese Medicine; ITT: intention-to-treat Reference Pang J 2009 13 Wang HF 2010 14 Zou YJ 2007 15 Yang XJ 2009 16 Chen W 2005 17 Zhou YX 2012 18 Chen Y 2004 19 Zhang ZL 2007 20 Tan HL 2009 21 Li JS 2008 22 Li D 2011 23 Li YH 2009 24 Glycyrrhizae) were mostly used, and the dosages were 9-15 g, 9-15 g, and 6-10 g, respectively.
DISCUSSION
Herbal medications provide symptom relief in FD, and the evidence grade is moderate. 27 They have a long history of use in the treatment of dyspeptic complaints. Their mechanisms of action are not completely understood. However, findings suggest that herbal medications might modulate the activity of the smooth musculature of the digestive tract. 28 The results of our meta-analysis of data from 13 trials suggest that TCM has higher effective and cure rates in treating FD of liver-stomach disharmony syndrome than routine prokinetic agents (domperidone or mosapride). However, all identified studies were of poor quality. No study adopted blinding, concealment, and all the trials were conducted from single centers, which all influenced the reliability of this systematic review. There was no specific adverse effects mentioned in the TCM group, and only one study mentioned that domperidone had an adverse effect of epigastric discomfort and morepassing flatuses. Although some traditional Chinese herbal medicines were reported to be toxic, 29 herbal medicine still plays an important role in treating chronic diseases in China with fewer adverse effects reported. Figure 4 shows the frequency of chosen herbs in treating FD with liver-stomach disharmony syndrome. The frequently-used herbs (>6/13) were Baishao (Radix Paeoniae), Chaihu (Radix Bupleuri), Gancao (Radix Glycyrrhizae), Xiangfu (Rhizoma Cyperi), Baizhu (Rhizoma Atractylodis Macrocephalae), Zhishi (Fructus Aurantii Immaturus), Zhiqiao (Fructus Aurantii), Foshou (Citrus Medica var. Sarcodactylis), and Chenpi (Pericarpium Citri Reticulatae), of which the major effects are soothing the liver and regulating Qi. In addition, these herbs constitute the majority of a famous traditional Chinese prescription called Chaihu Shugan Powder (Bupleurm Powder for Dispersing Depressed Liver-Qi), which relieves depression of the liver-Qi, and promotes the circulation of Qi and relieves pain. 30 This treatment aims to treat the syndrome of stagnation of Qi due to depression of the liver, focusing on the manifestations of stagnation of Qi and pain on the liver meridian area. This review indirectly reveals that there is close connection between the syndrome of stagnation of Qi due to depression and the syndrome of liver-stomach disharmony. The syndrome of stagnation of Qi due to depression can lead to the syndrome of liver-stomach disharmony according to the five-element theory of TCM. In other words, this is called "wood restricting earth". Therefore, dispersing the depressed liver-Qi and regulating Qi for harmonizing the stomach 
